Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: A short-term follow-up study

Journal of Sexual Medicine

Volumn 4, Issue 6, 2007, Pages 1701-1707

  Paick, Jae Seung ^a   Um, Jin Mo ^a   Kim, Soo Woong ^a   Ku, Ja Hyeon ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

BenignProstatic Hyperplasia; ErectileFunction; LaserSurgery; Prostate; Vaporization

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW RATE; FUNCTIONAL ASSESSMENT; HIGH POWER POTASSIUM TITANYL PHOSPHATE PHOTOSELECTIVE LASER VAPORIZATION; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LASER SURGERY; LOWER URINARY TRACT SYMPTOM; MALE; PENIS ERECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RESIDUAL URINE; SEXUAL FUNCTION; TREATMENT RESPONSE; VAPORIZATION;

EID: 35448970216     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00574.x     Document Type: Article

References (32)

1. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: Observations on long-term outcomes. J Urol 2005; 174: 1344-8.
2. Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Muller A, Sulser T. Photoselective vaporization of the prostate: The basel experience after 108 procedures. Eur Urol 2005; 47: 798-804.
3. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: Early results of a randomized trial. J Endourol 2006; 20: 580-5.
4. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Potassium-titanyl-phosphate laser vaporization of the prostate: A comparative functional and pathologic study in canines. Urology 1996; 48: 575-83.
5. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997; 49: 703-8.
6. Bachmann A, Schurch L, Ruszat R, Seifert HH, Muller A, Lehmann K, Sulser T. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): A prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005; 48: 965-71.
7. Chung TG, Lee TK, Chung S, Lee MS, Kim YS, Ahn TY. The Korean version of the International Index of Erectile Function (IIEF): Reliability and validation study. Korean J Urol 1999; 40: 1334-43.
8. Rosenbaum TY. Pelvic floor involvement in male and female sexual dysfunction and the role of pelvic floor rehabilitation in treatment: A literature review. J Sex Med 2007; 4: 4-13.
9. Laumann EO, West S, Glasser D, Carson C, Rosen R, Kang JH. Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: From the male attitudes regarding sexual health survey. J Sex Med 2007; 4: 57-65.
10. McVary KT. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol 2005; 47: 838-45.
11. Costabile RA, Steers WD. How can we best characterize the relationship between erectile dysfunction and benign prostatic hyperplasia? J Sex Med 2006; 3: 676-81.
12. Blanker MH, Bohnen AM, Groeneveld FP, Groeneveld FP, Bohnen AM, Prins A, Thomas S, Hop WC. Correlates for erectile and ejaculatory dysfunction in older Dutch men: A community-based study. J Am Geriatr Soc 2001; 49: 436-42.
13. Green JS, Holden ST, Bose P, George DP, Bowsher WG. An investigation into the relationship between prostate size, peak urinary flow rate and male erectile dysfunction. Int J Impot Res 2001; 13: 322-5.
14. Macfarlane GJ, Botto H, Sagnier PP, Teillac P, Richard F, Boyle P. The relationship between sexual life and urinary condition in the French community. J Clin Epidemiol 1996; 49: 1171-6.
15. Frankel SJ, Donovan JL, Peters TI, Abrams P, Dabhoiwala NF, Osawa D, Lin AT. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 1998; 51: 677-85.
16. Terai A, Ichioka K, Matsui Y, Toshimura K. Association of lower urinary tract symptoms with erectile dysfunction in Japanese men. Urology 2004; 64: 132-6.
17. Shiri R, Hakkinen J, Koskimaki J, Huhtala H, Auvinen A, Hakama M, Tammela TL. Association between the bothersomeness of lower urinary tract symptoms and the prevalence of erectile dysfunction. J Sex Med 2005; 2: 438-44.
18. El-Sakka AI. Lower urinary tract symptoms in patients with erectile dysfunction: Analysis of risk factors. J Sex Med 2006; 3: 144-9.
19. Takeda M, Tang R, Shapiro E, Burnett AL, Lepor H. Effects of nitric oxide on human and canine prostates. Urology 1995; 45: 440-6.
20. Sairam K, Kulinskaya E, McNicholas TA, Boustead GB, Hanbusry DC. Sildenafil influences lower urinary tract symptoms. BJU Int 2002; 90: 836-9.
21. Mulhall JP, Guhring P, Parker M, Hopps C. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. J Sex Med 2006; 3: 662-7.
22. Gonzalez RR, Kaplan SA. Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Expert Opin Drug Metab Toxicol 2006; 2: 609-17.
23. Parsons CI. Impotence following transurethral resection of the prostate. In: Rajfer J, ed. Common problems in infertility and impotence. Chicago, IL: Year Book Medical; 1990: 352-5.
24. Poulakis V, Ferakis N, Witzsch U, de Vries R, Becht E. Erectile dysfunction after transurethral prostatectomy for lower urinary tract symptoms: Results from a center with over 500 patients. Asian J Androl 2006; 8: 69-74.
25. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995; 332: 75-9.
26. Uygur MC, Gur E, Arik AI, Altug U, Erol D. Erectile dysfunction following treatments of benign prostatic hyperplasia: A prospective study. Andrologia 1998; 30: 5-10.
27. Tscholl R, Largo M, Poppinghaus E, Recker F, Subotic B. Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative snap gauge tests. J Urol 1995; 153: 1491-3.
28. Brookes ST, Donovan JL, Peters TJ, Abrams P, Neal DE. Sexual dysfunction in men after treatment for lower urinary tract symptoms: Evidence from randomised controlled trial. BMJ 2002; 324: 1059-61.
29. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institution evaluation 3,885 patients. J Urol 1989; 141: 243-7.
30. Leliefeld HHJ, Stoevelaar HJ, McDonnel J, Sexual function before and after various treatment for symptomatic benign prostatic hyperplasia. BJU Int 2002; 89: 209-13.
31. Roehrborn CG. Standard surgical interventions: TURP/TUIP/OPSU. In: Kirby R, McConnell J, Fitzpatrick J, eds. Textbook of benign prostatic hyperplasia. Oxford, UK: ISIS Medical Media; 1996: 341-78.
32. Moreira ED Jr, Kim SC, Glasser D, Gingell C. Sexual activity, prevalence of sexual problems, and associated help-seeking patterns in men and women aged 40-80 years in Korea: Data from the global study of sexual attitudes and behaviors (GSSAB). J Sex Med 2006; 3: 201-11.